The company was founded in 2019 in Stockholm and was then accepted into the Karolinska Institute DRIVE incubator program. Among the co-founders are the Professor and Senior Consultant in diabetes, Per-Ola Carlsson (M.D. PhD.) and the Associate Professor and Senior Consultant, Daniel Espes (M.D. PhD), from Uppsala University, both possessing great expertise in diabetes. Today, OneTwo Analytics consists of a versatile team with expertise in medical technology, clinical development, regulations, artificial intelligence, machine learning, design and healthcare management.
OneTwo Analytics is a medtech company with the vision to simplify the management of diabetes for both healthcare professionals and individuals living with diabetes. With technological advancements and the introduction of CGM sensors, there is a large amount of accessible health data about each individual. With this data, we can customize, develop and optimize diabetes care in a way that was not possible before. Using AI/ML, OneTwo Analytics interprets the large amount of data flowing through users' CGM sensors. This makes it easier to understand and tailor treatments, both in diabetes care and in self-care.
OneTwo Analytics offers AI/ML-based services for diabetes care and individuals living with diabetes. Our services are at the forefront of the digital transformation in diabetes care, supporting healthcare professionals in quickly interpreting large amounts of data from glucose sensors. OneTwo Analytics enables improved quality of life, better treatment outcomes, increased capacity, and more efficient operations.